Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:TSM) was upgraded by investment analysts at Bank of America from a “neutral” rating to a “buy” rating in a note issued to investors on Monday. The firm currently has a $27.62 price objective on the stock, up from their previous price objective of $22.00. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) belongs to Technology sector. Its net profit margin is 31.60% and weekly performance is 1.05%. On last trading day company shares ended up $22.20. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) distance from 50-day simple moving average (SMA50) is 1.59%.
On Dec. 9, Glacier Peak U.S. Value Fund, L.P., a long term shareholder of Volt Information Sciences Inc. (NYSEMKT:VISI), has nominated four highly qualified director candidates for election to the Company’s Board of Directors (the “Board”) at Volt’s 2015 Annual Meeting of Shareholders (the “2015 Annual Meeting”). Volt Information Sciences Inc. (NYSEMKT:VISI) shares decreased -10.00% in last trading session and ended the day at $10.26. VISI Gross Margin is 91.70% and its return on assets is -4.30%. Volt Information Sciences Inc. (NYSEMKT:VISI) quarterly performance is 9.73%.
On Dec 17, General Mills, Inc. (NYSE:GIS) affirmed its full-year forecast and reported a higher-than-expected quarterly profit on Wednesday, and the maker of Cheerios cereal and Betty Crocker cake mixes said it would increase sales through new products. On 19 December, General Mills, Inc. (NYSE:GIS) shares increased 0.56% and was closed at $53.81. GIS EPS growth in last 5 year was 8.30%. General Mills, Inc. (NYSE:GIS) year to date (YTD) performance is 11.27%.
Shares of Arena Pharmaceuticals (NASDAQ:ARNA) saw a significant drop in short interest in the month of November. As of November 14th, there was short interest totalling 39,144,911 shares, a drop of 3.9% from the October 31st total of 40,735,338 shares, AnalystRatingsNetwork.com reports. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) ended the last trading day at $3.99. Company weekly volatility is calculated as 5.08% and price to cash ratio as 4.66. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) showed a weekly performance of 2.05%.
America Movil SAB de CV (NYSE:AMX) has been given an average rating of “Hold” by the nine brokerages that are presently covering the company, Stock Ratings Network reports. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating on the company. America Movil S.A.B. de C.V. (NYSE:AMX) shares decreased -0.92% in last trading session and ended the day at $21.59. AMX Gross Margin is 51.00% and its return on assets is 10.40%. America Movil S.A.B. de C.V. (NYSE:AMX) quarterly performance is -15.86%.